Advertisement
ACRS vs UFPT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Hold and UFPT is a Hold.
ACRS in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 01, 2026
ACRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 32 cases where ACRS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACRS's RSI Oscillator exited the oversold zone, 25 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for ACRS just turned positive on October 21, 2026. Looking at past instances where ACRS's MACD turned positive, the stock continued to rise in 35 of 43 cases over the following month. The odds of a continued upward trend are 81%.
Following a +5.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACRS advanced for three days, in 222 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 62 cases where ACRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACRS as a result. In 73 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ACRS entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.348) is normal, around the industry mean (2.904). P/E Ratio (-6.345) is within average values for comparable stocks, (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (83.333) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. ACRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
UFPT in downward trend: 10-day moving average crossed below 50-day moving average on November 02, 2026
The 10-day moving average for UFPT crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for UFPT moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 27 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 61%.
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UFPT as a result. In 57 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for UFPT turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 38 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
UFPT moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UFPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for UFPT entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where UFPT advanced for three days, in 275 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
UFPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. UFPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.525) is normal, around the industry mean (4.170). P/E Ratio (35.200) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (5.110) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (3.449) is also within normal values, averaging (40.124).
ACRS | UFPT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 46 Fair valued | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 37 | |
SMR RATING 1..100 | 98 | 52 | |
PRICE GROWTH RATING 1..100 | 64 | 47 | |
P/E GROWTH RATING 1..100 | 15 | 27 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ACRS's Valuation (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for UFPT (90) in the Containers Or Packaging industry. This means that ACRS’s stock grew somewhat faster than UFPT’s over the last 12 months.
UFPT's Profit vs Risk Rating (37) in the Containers Or Packaging industry is somewhat better than the same rating for ACRS (100) in the Pharmaceuticals Other industry. This means that UFPT’s stock grew somewhat faster than ACRS’s over the last 12 months.
UFPT's SMR Rating (52) in the Containers Or Packaging industry is somewhat better than the same rating for ACRS (98) in the Pharmaceuticals Other industry. This means that UFPT’s stock grew somewhat faster than ACRS’s over the last 12 months.
UFPT's Price Growth Rating (47) in the Containers Or Packaging industry is in the same range as ACRS (64) in the Pharmaceuticals Other industry. This means that UFPT’s stock grew similarly to ACRS’s over the last 12 months.
ACRS's P/E Growth Rating (15) in the Pharmaceuticals Other industry is in the same range as UFPT (27) in the Containers Or Packaging industry. This means that ACRS’s stock grew similarly to UFPT’s over the last 12 months.
| ACRS | UFPT | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | 2 days ago 61% |
| Stochastic ODDS (%) | 1 day ago 79% | 2 days ago 78% |
| Momentum ODDS (%) | 1 day ago 79% | 2 days ago 64% |
| MACD ODDS (%) | 1 day ago 81% | 2 days ago 72% |
| TrendWeek ODDS (%) | 1 day ago 81% | 2 days ago 70% |
| TrendMonth ODDS (%) | 1 day ago 77% | 2 days ago 69% |
| Advances ODDS (%) | 7 days ago 82% | 24 days ago 82% |
| Declines ODDS (%) | 1 day ago 84% | 2 days ago 71% |
| BollingerBands ODDS (%) | 3 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 1 day ago 80% | 2 days ago 59% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACRS’s FA Score shows that 1 FA rating(s) are green while UFPT’s FA Score has 1 green FA rating(s).
- ACRS’s FA Score: 1 green, 4 red.
- UFPT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACRS’s TA Score shows that 4 TA indicator(s) are bullish while UFPT’s TA Score has 3 bullish TA indicator(s).
- ACRS’s TA Score: 4 bullish, 4 bearish.
- UFPT’s TA Score: 3 bullish, 7 bearish.
Price Growth
ACRS (@Biotechnology) experienced а -7.07% price change this week, while UFPT (@Medical/Nursing Services) price change was -4.92% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -11.00%, and the average quarterly price growth was -16.20%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.95%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was -1.38%.
Reported Earning Dates
ACRS is expected to report earnings on Nov 05, 2026.
UFPT is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Biotechnology (-3.38% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Medical/Nursing Services (+1.95% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
UFPT and
Correlation & Price change
A.I.dvisor indicates that over the last year, UFPT has been loosely correlated with TCMD. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if UFPT jumps, then TCMD could also see price increases.
| Ticker / NAME | Correlation To UFPT | 1D Price Change % | ||
|---|---|---|---|---|
| UFPT | 100% | -1.29% | ||
| TCMD - UFPT | 49% Loosely correlated | +8.35% | ||
| LMAT - UFPT | 42% Loosely correlated | -0.81% | ||
| ACRS - UFPT | 39% Loosely correlated | -1.58% | ||
| ATR - UFPT | 38% Loosely correlated | -1.08% | ||
| AMIX - UFPT | 37% Loosely correlated | -1.19% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VALG | 13.49 | N/A | N/A |
| Leverage Shares 2X Long VALE Daily ETF (VALG) | |||
| APIE | 37.65 | -0.06 | -0.16% |
| ActivePassive International Equity ETF (APIE) | |||
| EVLU | 39.12 | -0.23 | -0.59% |
| iShares MSCI Emerging Markets Value Factor ETF (EVLU) | |||
| AVNV | 81.10 | -0.60 | -0.73% |
| Avantis All International Markets Value ETF (AVNV) | |||
| KSTR | 16.72 | -0.43 | -2.51% |
| KraneShares China Technology & Semiconductor STAR 50 Index ETF (KSTR) | |||